Search Results

You are looking at 241 - 250 of 1,601 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Adverse Events Reported by Patients With Cancer After Administration of a 2-Dose mRNA COVID-19 Vaccine

Rebecca M. Shulman, David S. Weinberg, Eric A. Ross, Karen Ruth, Glenn F. Rall, Anthony J. Olszanski, James Helstrom, Michael J. Hall, Julia Judd, David Y.T. Chen, Robert G. Uzzo, Timothy P. Dougherty, Riley Williams, Daniel M. Geynisman, Carolyn Y. Fang, Richard I. Fisher, Marshall Strother, Erica Huelsmann, Sunil Adige, Peter D. Whooley, Kevin Zarrabi, Brinda Gupta, Pritish Iyer, Melissa McShane, Hilario Yankey, Charles T. Lee, Nina Burbure, Lauren E. Laderman, Julie Giurintano, Samuel Reiss, and Eric M. Horwitz

extended to 90 days before the first vaccine dose. Early symptom onset was defined as an adverse event within 24 hours of vaccination. Baseline characteristics of the study population were tabulated separately for patients without cancer, unselected

Full access

Do Editorialists With Industry-Related Conflicts of Interest Write Unduly Favorable Editorials for Cancer Drugs in Top Journals?

Shubham Sharma, Christopher M. Booth, Elizabeth A. Eisenhauer, and Bishal Gyawali

published in the top journals, 243 were related to oncology. The final study cohort included 90 editorials based on the inclusion and exclusion criteria ( Figure 1 ). Characteristics of the editorials and their accompanying clinical trials are shown in

Full access

Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer?

Yifan Wang, Adeline Cuggia, Yen-I Chen, Josée Parent, Agatha Stanek, Robert E. Denroche, Amy Zhang, Robert C. Grant, Céline Domecq, Bryn Golesworthy, Chaya Shwaartz, Ayelet Borgida, Spring Holter, Julie M. Wilson, George Chong, Grainne M. O’Kane, Jennifer J. Knox, Sandra E. Fischer, Steven Gallinger, Zu-Hua Gao, William D. Foulkes, Kevin A. Waschke, and George Zogopoulos

. Cohen’s kappa was used to calculate the intermodality agreement between MRI and EUS. A P value <.05 was considered statistically significant. Results Characteristics of HRIs Seventy-five HRIs from 60 families completed at least one

Full access

Maintenance of Fitness and Quality-of-Life Benefits From Supervised Exercise Offered as Supportive Care for Breast Cancer

Amy A. Kirkham, Kelcey A. Bland, Holly Wollmann, Alis Bonsignore, Don C. McKenzie, Cheri Van Patten, Karen A. Gelmon, and Kristin Campbell

characteristics were extracted from medical records. Assessments included physical fitness tests and questionnaires, and were performed at the following time points: (1) baseline/enrollment, (2) end of treatment (1 week after radiotherapy if received, or the

Full access

Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA

Li-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, Shan-Shan Guo, Ling Guo, Hao-Yuan Mo, Yang Li, Qing-Nan Tang, Xue-Song Sun, Yu-Jing Liang, Chong Zhao, Xiang Guo, Chao-Nan Qian, Mu-Sheng Zeng, Jin-Xin Bei, Ming-Huang Hong, Jian-Yong Shao, Ying Sun, Jun Ma, and Hai-Qiang Mai

antigen immunoglobulin A. Tests were 2-sided, and a P value <.05 was considered significant. Results The characteristics of the 2,263 patients in the different treatment groups are presented in Table 1 . In the NACT + CCRT group (N=1,073), 81.5% of

Full access

Conditional Survival and Cure of Patients With Colon or Rectal Cancer: A Population-Based Study

Seyed M. Qaderi, Paul W. Dickman, Johannes H.W. de Wilt, and Rob H.A. Verhoeven

data from the Netherlands Cancer Registry (NCR). 13 All patients newly diagnosed with cancer are registered in the nationwide NCR. Information regarding patient and tumor characteristics are extracted directly from medical records by trained NCR data

Full access

Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies

Elio Mazzone, Sophie Knipper, Francesco A. Mistretta, Carlotta Palumbo, Zhe Tian, Andrea Gallina, Derya Tilki, Shahrokh F. Shariat, Francesco Montorsi, Fred Saad, Alberto Briganti, and Pierre I. Karakiewicz

.29). 14 , 18 Only patients with a secondary diagnosis of metastatic disease were included (ICD-9-CM codes 197.x and 198.x). These selection criteria yielded 1,944 patients. Patient and Hospital Characteristics Patient age at admission, year of admission

Full access

Predictors of Locoregional Recurrence After Failure to Achieve Pathologic Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Prashant Gabani, Emily Merfeld, Amar J. Srivastava, Ashley A. Weiner, Laura L. Ochoa, Dan Mullen, Maria A. Thomas, Julie A. Margenthaler, Amy E. Cyr, Lindsay L. Peterson, Michael J. Naughton, Cynthia Ma, and Imran Zoberi

. Statistical analysis was performed using SPSS Statistics, version 25 (IBM Corporation), and P <.05 was considered statistically significant. Results A total of 153 patients were included in the analysis; baseline characteristics are shown in Table 1 . Median

Full access

Pilot Trial of Streamlined Genetic Education and Traceback Genetic Testing in Prostate Cancer Survivors

Marc D. Schwartz, Beth N. Peshkin, Claudine Isaacs, Christopher Grisham, Nora J. Holmes, Lia J. Sorgen, Sean Collins, Nancy Dawson, Colleen McGuire, Tobechukwu Okobi, Kelsey Newell, Kavitha A. Kolla, and Veronique Weinstein

Institute Inc.) for all analyses. Results Table 1 displays the sociodemographic and clinical characteristics of the study sample. Table 1. Sample Characteristics Genetic Testing and Genetic Counseling Participation A total of 37 (34

Full access

Contemporary Population-Based Analysis of Bone Mineral Density Testing in Men Initiating Androgen Deprivation Therapy for Prostate Cancer

Jason Hu, Armen G. Aprikian, Marie Vanhuyse, and Alice Dragomir

,586). Results Cohort Characteristics A total of 22,033 patients were included in the cohort with a mean age of 75 years. Prior diagnosis of osteoporosis and use of bisphosphonates were found in 1.2% and 6.3% of the cohort, respectively. Most patients were